![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_46b3a2c8891e0a5c463496705bd53690.svg) | (2-(2',6'-Dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane | IC50 | 1.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_fe0752a8b8d7dcc41cb04f6c3cbe759b.svg) | Tamsulosin | IC50 | 2.2 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_628cf5c819819c75fc97c108403b82dd.svg) | Methyl 5-[3-(4,4-diphenylpiperidin-1-yl)propylcarbamoyl]-2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3-carboxylate | Ki | 1.3 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_be4565ca8c20c1d9804fa640fd1584d5.svg) | Risperidone | IC50 | 10.0 [1], 10.9 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_be4565ca8c20c1d9804fa640fd1584d5.svg) | Risperidone | Ki | 2.3 [1], 2.8 [2], 10.0 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_abaf387535b47aae3a9dfa84743be0c3.svg) | Aripiprazole | IC50 | 170.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_abaf387535b47aae3a9dfa84743be0c3.svg) | Aripiprazole | Ki | 26.0 [1], 100.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_3d96615c46a239eb07c6cfebdb122015.svg) | Doxazosin | Ki | 0.54 [1], 0.78 [2], 2.6 [3], 3.16 [4] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_61b54f6a9d8fde0cb2e300ef5abb08c9.svg) | Naftopidil | IC50 | 555.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_61b54f6a9d8fde0cb2e300ef5abb08c9.svg) | Naftopidil | Ki | 3.7 [1], 3.71 [2], 5.88 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_eca0cdb299e75956aee8a17ffc18de04.svg) | 3-[1-[4-(5-Chloro-1,1,3-trioxo-1,2-benzothiazol-2-yl)butyl]piperidin-4-yl]-1,3-benzoxazol-2-one | Ki | 0.08 [1], 0.17 [2], 0.24 [3], 74.0 [4], 90.0 [5] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_2f8b1a65fcaa2c2002b0eddc770532aa.svg) | Silodosin | IC50 | 1.8 [1], 1.9 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_2f8b1a65fcaa2c2002b0eddc770532aa.svg) | Silodosin | Ki | 0.04 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_a48ee907e46c34256bd466f58a4afd5c.svg) | Cyclazosin | Ki | 5.5 [1], 12.3 [2], 25.12 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_b46a2577496f41af96e22052685ef08f.svg) | 3-[2-[4-(2-Methoxyphenyl)-1-piperazinyl]ethyl]-1,5-dihydropyrimido[5,4-b]indole-2,4-dione | Ki | 0.27 [1], 0.29 [2], 3.72e+18 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_da3a4948f404fa572f0ac6e028f676fa.svg) | (4S,5S)-4-(3,4-Difluorophenyl)-N-[3-[4-(4-fluorophenyl)piperidin-1-yl]propyl]-5-methyl-2-oxo-1,3-oxazolidine-3-carboxamide | Ki | 0.17 [1], 0.23 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_ab1ab4ef07b41b9f04486287fd7265b9.svg) | 8-[(2R)-1-[4-(2,4,5-Trifluorophenyl)piperazin-1-yl]propan-2-yl]-8-azaspiro[4.5]decane-7,9-dione | Ki | 290.0 [1], 294.0 [2], 14000.0 [3], 14900.0 [4] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_f55cc3c3d081e9b01c9a5590a44a3b44.svg) | 5-N-[3-(4,4-Diphenylpiperidin-1-yl)propyl]-3-N,2,6-trimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxamide | Ki | 3.1 [1], 3.16 [2], 4.47 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_353de4856aad482e432e828dd0efa8b5.svg) | 5-N-[3-(4,4-Diphenylpiperidin-1-yl)propyl]-2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxamide | Ki | 1.3 [1], 1.86 [2], 1.87 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_5f6b1128b3253286953ce0b4d920043e.svg) | N-((1r,4r)-4-(4-(2-Cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide | Ki | 0.91 [1], 11.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_d64ff67e90175d413c9f5dcf3016be21.svg) | N-((1r,4r)-4-(4-(2-Isopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide | Ki | 1.8 [1], 2.2 [2], 28.0 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_7144d123238b854bbde00080619e7f09.svg) | 3,4-Dimethoxy-N-[4-[4-[2-(2,2,2-trifluoroethoxy)phenyl]piperidin-1-yl]cyclohexyl]benzenesulfonamide | Ki | 1.8 [1], 21.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_f9039ce6bbf46370f0f0b0f9596f9c5e.svg) | N-((1r,4r)-4-(4-(2-(2-Fluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide | Ki | 8.5 [1], 11.0 [2], 69.0 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_f8f80c78dd47ec14086988730d776a2f.svg) | N-[4-[4-[2-(2,2-Difluoroethoxy)phenyl]piperidin-1-yl]cyclohexyl]-3,4-dimethoxybenzenesulfonamide | Ki | 12.0 [1], 31.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_25c5cb3558564838a1f2f6cd6a2ee4af.svg) | 3,4-Dimethoxy-N-[4-[4-(2-propan-2-yloxyphenyl)piperazin-1-yl]cyclohexyl]benzenesulfonamide | Ki | 1.6 [1], 2.0 [2], 23.0 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_8159b09a6bebd9e5751360e57f770ab8.svg) | Clozapine | Ki | 10.0 [1], 19.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_8b78ef0953132cb6729f40caa0d6bbea.svg) | Olanzapine | Ki | 60.0 [1], 1000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_e684ff905325760b5d18575644f1108f.svg) | Phentolamine | Ki | 0.6 [1], 4.12 [2], 12.0 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_e3096b66767b9a59542159f718830971.svg) | Azelastine | Ki | 50.12 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_09d61e0b7585577e0b350506f4f4c16d.svg) | 8-(2-(4-(2-Methoxyphenyl)piperazin-1-yl)ethyl)-8-azaspiro[4.5]decane-7,9-dione dihydrochloride | Ki | 42.66 [1], 251.19 [2], 380.19 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_45dcbd1bf64013c2b1cc683f9b147e16.svg) | Niguldipine | Ki | 0.16 [1], 1.8 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_1fda4985931c2c480c4e88e39e59e589.svg) | Upidosin | Ki | 0.34 [1], 1.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_aaf0c948ec6905346ef46a5321d52fb9.svg) | 7-Chloro-2-ethenyl-3,4,5,6-tetrahydro-4-methylthieno(4,3,2-ef)(3)benzazepine | Ki | 25.12 [1], 36.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_7ad51d7da861e542463461d48139ba35.svg) | Benzyl (2S)-4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-2-(tert-butylcarbamoyl)piperazine-1-carboxylate | IC50 | 590.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_7ad51d7da861e542463461d48139ba35.svg) | Benzyl (2S)-4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-2-(tert-butylcarbamoyl)piperazine-1-carboxylate | Ki | 420.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_aa92cb575f0456161594c002e3244813.svg) | CID 9872515 | Ki | 1.0 [1], 1.26 [2], 1.3 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_c3ac8b3671d02adb7e16b67e109c0efe.svg) | 2-[[(2R)-1-[4-[4-[3-(Azepan-1-yl)propoxy]phenyl]butyl]pyrrolidin-2-yl]methyl]-4-[(4-chlorophenyl)methyl]phthalazin-1-one | Ki | 39.81 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_4453feaaab4157d3691abc3d53b4a76c.svg) | N-[[(3S)-2,3-Dihydro-1,4-benzodioxin-3-yl]methyl]-2-(2,6-dimethoxyphenoxy)ethanamine;hydrochloride | Ki | 0.41 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_d70a81e024e37dc8dc5b94ad4f093ec9.svg) | N,N-Dimethyl-1-(3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-yl)methanamine | IC50 | 537.03 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_09496d3520391d098ba91bc7bd71681d.svg) | Methyl 4-(3,4-difluorophenyl)-3-[3-(4-methoxycarbonyl-4-phenylpiperidin-1-yl)propylcarbamoyl]-6-methyl-2-oxo-1,4-dihydropyrimidine-5-carboxylate | Ki | 0.1 [1], 1.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_3f9f85b39a39a1d6cb0eeb1e9970d8e1.svg) | 5-N-[4-(4,4-Diphenylpiperidin-1-yl)butyl]-2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxamide | Ki | 1.86 [1], 1.87 [2], 1.9 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_d14bb93839d4d29e6d80a2e4086dd705.svg) | Methyl 5-[4-(4,4-diphenylpiperidin-1-yl)butylcarbamoyl]-2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3-carboxylate | Ki | 5.89 [1], 14.79 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_f0114ca81bcb55659b95b0c2962714e8.svg) | Methyl 5-[3-(4-methoxycarbonyl-4-phenylpiperidin-1-yl)propylcarbamoyl]-2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3-carboxylate | Ki | 3.55 [1], 3.58 [2], 3.6 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_598fcce9dc0151b23668cb40b023cc0b.svg) | 1-(1,4-Dioxaspiro[4.5]decan-3-ylmethyl)-4-(2-methoxyphenyl)piperazine | Ki | 91.2 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_b9c45eb2042fa8caa502ce4b5f696301.svg) | N-[(2,2-Diphenyl-1,3-dioxolan-4-yl)methyl]-2-phenoxyethanamine;oxalic acid | Ki | 37.15 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_cfb747e4f0c92f2364a8cc861d904983.svg) | Methyl 1-[3-[[5-carbamoyl-6-ethyl-4-(4-nitrophenyl)-2-oxo-1,4-dihydropyrimidine-3-carbonyl]amino]propyl]-4-phenylpiperidine-4-carboxylate | Ki | 0.19 [1], 0.5 [2], 1.9 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_1a2ef0969fddb77e7c383253c8b871b7.svg) | Clonidine | Ki | 512.86 [1], 977.24 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_c871e436119b1d6f92ea7571ed4647e5.svg) | Quetiapine | Ki | 20.0 [1], 100.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_b1a69169af7ce803f34e08ec3e1a1109.svg) | Corynanthine | Ki | 29.0 [1], 142.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_b329cb5fecb003fb4c92d7c3545f5228.svg) | Mianserin | IC50 | 407.38 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_f0b974acce173ed1efad29446af0c351.svg) | Cyclohexanecarboxamide, n-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-n-2-pyridinyl- | Ki | 18.62 [1], 20.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_be653f89bf9757f77ea6b06dba105b92.svg) | Alfuzosin | Ki | 8.2 [1], 10.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_cff59dd686ac48dc984e2eb35145cf4a.svg) | Rilmenidine | Ki | 6025.6 [1], 8912.51 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_2b4ce30e56f11a10ec74519d3bcc2a34.svg) | 1-(2-Methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine | Ki | 0.26 [1], 2.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_01e12972ea4730f06a2b9903f3170d50.svg) | Indoramin | Ki | 3.7 [1], 3.98 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_dbc04cc2bb288e3684ed846b2d98ba3b.svg) | 5-Methylurapidil | Ki | 0.63 [1], 2.3 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_a5f6b839e0f27ed6fd77b5892e78922f.svg) | Dexniguldipine | Ki | 0.16 [1], 4.7 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_7e4ded7b2c14dc554f12b0242a500996.svg) | 1-(5-Chloro-1H-indol-3-yl)-N-[2-[2-(cyclopropylmethoxy)phenoxy]ethyl]-2-methylpropan-2-amine | Ki | 0.6 [1], 0.63 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_9e391a3068ebc37ba708e9a49c1e28cb.svg) | 5-Methyl-3-[3-[4-[2-(2,2,2-trifluoroethoxy)phenyl]piperazin-1-yl]propyl]-1H-pyrimidine-2,4-dione | Ki | 0.25 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_7e67dc53b9dda9b460fb3afbfa5076d7.svg) | N,N-Diallyl-5-methoxytryptamine | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_f6862d9b7ac388ca4aeeb7ba12aca515.svg) | Methyl (4R)-5-[3-(4,4-diphenylpiperidin-1-yl)propylcarbamoyl]-2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3-carboxylate | Ki | 0.18 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_8d514bfff5768fe4ef7c43d9798c0d1f.svg) | 5-[2-[(3Ar,9bR)-6-methoxy-1,3,3a,4,5,9b-hexahydrobenzo[e]isoindol-2-yl]ethyl]-8-thia-3,5,13-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),10,12-tetraene-4,6-dione | Ki | 0.22 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_a0b09fab2d611112d3464cc7ebe53846.svg) | 2-(2-Biphenylyloxymethyl)-2-imidazoline | IC50 | 27.54 [1], 66.07 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_3c0758265a38ce6e1730bfca3f5b5333.svg) | 3-[2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl]-5-phenyl-1H-thieno[2,3-d]pyrimidine-2,4-dione | Ki | 2.6 [1], 2.63 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_6fb29d61b659d85f4cfb55da06cb24ed.svg) | N-[2-(2,6-Dimethoxyphenoxy)ethyl]-2-(2-phenylmethoxyphenoxy)ethanamine | Ki | 0.47 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_02734a576339a396f64668009536365f.svg) | 2-Bromo-7-chloro-11-methyl-3-oxa-11-azatricyclo[6.4.1.04,13]trideca-1,4(13),5,7-tetraene | Ki | 3300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_19c74a202170a17869adf39773a3b579.svg) | 2-(2-Oxopiperidin-1-yl)-N-[3-[4-(2-propan-2-yloxyphenyl)piperazin-1-yl]propyl]acetamide | Ki | 0.65 [1], 0.66 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_d089b799ea8f404d0444e00904da9092.svg) | 3-[2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl]-5-(3-methylphenyl)-1H-thieno[2,3-d]pyrimidine-2,4-dione | Ki | 4.17 [1], 4.2 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_f1b534cf1afba6733eb87d0240ba71e5.svg) | 2,9-Dimethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline-3,10-diol | Ki | 616.0 [1], 630.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_08c0971c1869066381e936848545bc75.svg) | 2-(2,6-Dimethoxyphenoxy)-N-[[(2R)-6,6-diphenyl-1,4-dioxan-2-yl]methyl]ethanamine | Ki | 165.96 [1], 338.84 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_a046fe66477fb00d53548d3fc5f8d779.svg) | N-[[(2R)-6,6-Diphenyl-1,4-dioxan-2-yl]methyl]-2-(2-methoxyphenoxy)ethanamine | Ki | 16.6 [1], 27.54 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_578f6b3954dcdeb8c030d8c880a5d0e8.svg) | N-[[(2R)-6,6-Diphenyl-1,4-dioxan-2-yl]methyl]-2-phenoxyethanamine | Ki | 128.82 [1], 169.82 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_26b4ce344ac3d8bc963fc816c7549973.svg) | (4S)-2-(2-Aminoethoxymethyl)-3-N-[3-(4,4-diphenylpiperidin-1-yl)propyl]-6-ethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxamide | Ki | 0.4 [1], 0.65 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_8342c3aea2030e0fc19ccbf45b947886.svg) | N-[[(3R)-2,3-Dihydro-1,4-benzodioxin-3-yl]methyl]-2-(2,6-dimethoxyphenoxy)ethanamine;hydrochloride | Ki | 11.22 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_e8bb1298c1e665355f328c579ddc117b.svg) | JTH-601 free base | Ki | 0.4 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_168a7314b3457982ddfcdb5ed5ed2465.svg) | Unii-M7ias8PR23 | Ki | 8.7 [1], 9.3 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_c2e44f9ae240776c7332033f252361e0.svg) | 2-(2-Oxoazepan-1-yl)-N-[2-[4-(2-propan-2-yloxyphenyl)piperazin-1-yl]ethyl]acetamide | Ki | 18.0 [1], 22.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_b375adc21a71cbe0cd48b1b84c9c7bed.svg) | 3-[2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl]-1H-[1]benzothiolo[3,2-d]pyrimidine-2,4-dione | Ki | 3.31 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_ccd4b240c8f337cb874bf51cb996a1d7.svg) | Methyl 1-[3-[[2,6-dimethyl-5-(methylcarbamoyl)-4-(4-nitrophenyl)-1,4-dihydropyridine-3-carbonyl]amino]propyl]-4-phenylpiperidine-4-carboxylate | Ki | 3.98 [1], 607.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_c6bd1aa4beb0907276a9c7af592d2310.svg) | (4R)-4-(3,4-Difluorophenyl)-N-[3-[4-(4-fluorophenyl)piperidin-1-yl]propyl]-6-(methoxymethyl)-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide | Ki | 0.24 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_176d1a3872da10db969250d52fdcd866.svg) | Methyl 1-[3-[[5-carbamoyl-4-(2,4-difluorophenyl)-6-ethyl-2-oxo-1,4-dihydropyrimidine-3-carbonyl]amino]propyl]-4-phenylpiperidine-4-carboxylate | Ki | 0.2 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_074cdccd9b9a3042d2200e59f90272ac.svg) | 1-(17-Chloro-3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(14),7,9,11,15,17-hexaen-4-yl)-N,N-dimethylmethanamine | IC50 | 14.45 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_333d5a636f7be5860b69cdeff218d62d.svg) | (4R)-4-(3,4-Difluorophenyl)-6-(methoxymethyl)-2-oxo-N-[3-(4-pyridin-2-ylpiperidin-1-yl)propyl]-3,4-dihydro-1H-pyrimidine-5-carboxamide | Ki | 0.45 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_f23a8abbf0b24181e7484636f6b88e16.svg) | (4R)-N-[3-[4-(2-Cyanophenyl)piperidin-1-yl]propyl]-4-(3,4-difluorophenyl)-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide | Ki | 0.13 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_d4b7c9011e702bb2a90581e2f7f2deb9.svg) | (4R)-4-(3,4-Difluorophenyl)-N-[3-[4-(4-fluorophenyl)piperidin-1-yl]propyl]-1,3,6-trimethyl-2-oxo-4H-pyrimidine-5-carboxamide | Ki | 0.14 [1], 0.18 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_c8a559c468c5d46092c52530607a27db.svg) | (4R)-4-(3,4-Difluorophenyl)-N-[3-[4-(4-fluorophenyl)piperidin-1-yl]propyl]-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide | Ki | 0.17 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_4cb12c8234b85fd340bb8542e28f7ee0.svg) | Methyl (4R)-4-(3,4-difluorophenyl)-5-[3-[4-(4-fluorophenyl)piperidin-1-yl]propylcarbamoyl]-1,6-dimethyl-2-oxo-4H-pyrimidine-3-carboxylate | Ki | 0.75 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_0fbf0b4199855e630345b0acb4e62361.svg) | Methyl 4-(3,4-difluorophenyl)-3-[5-(4-methoxycarbonyl-4-phenylpiperidin-1-yl)pentyl]-6-methyl-2-oxo-1,4-dihydropyrimidine-5-carboxylate | Ki | 0.1 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_6a4b356c5efc3a3d4b24f83ce20a8687.svg) | (4R)-N-[3-[4-(2-Cyano-4-fluorophenyl)piperidin-1-yl]propyl]-4-(3,4-difluorophenyl)-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide | Ki | 0.07 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_6c1e4b0304cf5842fcafab33daf13625.svg) | (4R)-3-Acetyl-4-(3,4-difluorophenyl)-N-[3-[4-(4-fluorophenyl)piperidin-1-yl]propyl]-1,6-dimethyl-2-oxo-4H-pyrimidine-5-carboxamide | Ki | 2.2 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_fe570742b10c56dd0727f8fd63a62121.svg) | Methyl 1-[3-[[5-carbamoyl-2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3-carbonyl]amino]propyl]-4-phenylpiperidine-4-carboxylate | Ki | 0.84 [1], 2.4 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_13ca4eb6133cbcc6a9565cb6a5cb5c73.svg) | 3-[2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl]-2-methyl-5H-pyrimido[5,4-b]indol-4-one | Ki | 3.02 [1], 3.31e+17 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_eca8ec7a17340b65e9287a7d9930206a.svg) | 4-[(4-Chlorophenyl)methyl]-2-[[(2R)-1-methylpyrrolidin-2-yl]methyl]phthalazin-1-one | Ki | 25.12 [1], 31.62 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1a-adrenergic-receptor_b2d5c4d3b4ae880e24b60fc6997f2a83.svg) | 5-Chloro-2-methoxy-N-[4-[4-(2-propan-2-yloxyphenyl)piperazin-1-yl]cyclohexyl]benzenesulfonamide | Ki | 1.0 [1], 3.8 [2] |